Investigative Magnetic Resonance Imaging

Korean Society of Magnetic Resonance in Medicine (대한자기공명의과학회)
권호 표지
DOI QR코드

DOI QR Code

Optimization of Scan Parameters for in vivo Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging

  • Nguyen, Nguyen Trong (Department of Biomedical Science, Chonnam National University) ;
  • Rasanjala, Onila N.M.D. (Department of Artificial Intelligence Convergence, Chonnam National University) ;
  • Park, Ilwoo (Department of Artificial Intelligence Convergence, Chonnam National University)
  • Received : 2022.03.16
  • Accepted : 2022.03.21
  • Published : 2022.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this study was to investigate the change in signal sensitivity over different acquisition start times and optimize the scanning window to provide the maximal signal sensitivity of [1-13C]pyruvate and its metabolic products, lactate and alanine, using spatially localized hyperpolarized 3D 13C magnetic resonance spectroscopic imaging (MRSI). Materials and Methods: We acquired 3D 13C MRSI data from the brain (n = 3), kidney (n = 3), and liver (n = 3) of rats using a 3T clinical scanner and a custom RF coil after the injection of hyperpolarized [1-13C]pyruvate. For each organ, we obtained three consecutive 3D 13C MRSI datasets with different acquisition start times per animal from a total of three animals. The mean signal-to-noise ratios (SNRs) of pyruvate, lactate, and alanine were calculated and compared between different acquisition start times. Based on the SNRs of lactate and alanine, we identified the optimal acquisition start timing for each organ. Results: For the brain, the acquisition start time of 18 s provided the highest mean SNR of lactate. At 18 s, however, the lactate signal predominantly originated from not the brain, but the blood vessels; therefore, the acquisition start time of 22 s was recommended for 3D 13C MRSI of the rat brain. For the kidney, all three metabolites demonstrated the highest mean SNR at the acquisition start time of 32 s. Similarly, the acquisition start time of 22 s provided the highest SNRs for all three metabolites in the liver. Conclusion: In this study, the acquisition start timing was optimized in an attempt to maximize metabolic signals in hyperpolarized 3D 13C MRSI examination with [1-13C] pyruvate as a substrate. We investigated the changes in metabolic signal sensitivity in the brain, kidney, and liver of rats to establish the optimal acquisition start time for each organ. We expect the results from this study to be of help in future studies.

Keywords

Acknowledgement

This research was supported by the Ministry of Education, Republic of Korea (2019R1I1A3A01059201), a grant from Chonnam National University Hospital Biomedical Research Institute (BCRI22037), and the Molecular MR study group of KSMRM (2022).

References

  1. Kurhanewicz J, Vigneron DB, Ardenkjaer-Larsen JH, et al. Hyperpolarized 13C MRI: path to clinical translation in oncology. Neoplasia 2019;21:1-16 https://doi.org/10.1016/j.neo.2018.09.006
  2. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 2003;100:10158-10163 https://doi.org/10.1073/pnas.1733835100
  3. Wang ZJ, Ohliger MA, Larson PEZ, et al. Hyperpolarized 13C MRI: state of the art and future directions. Radiology 2019;291:273-284 https://doi.org/10.1148/radiol.2019182391
  4. Vaeggemose M, F Schulte R, Laustsen C. Comprehensive literature review of hyperpolarized carbon-13 MRI: the road to clinical application. Metabolites 2021;11:219 https://doi.org/10.3390/metabo11040219
  5. Park I, Larson PEZ, Gordon JW, et al. Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn Reson Med 2018;80:864-873 https://doi.org/10.1002/mrm.27077
  6. Park I, Hu S, Bok R, et al. Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D 13C magnetic resonance spectroscopic imaging. Magn Reson Med 2013;70:33-39 https://doi.org/10.1002/mrm.24434
  7. Park I, Kim S, Pucciarelli D, et al. Differentiating radiation necrosis from brain tumor using hyperpolarized carbon-13 MR metabolic imaging. Mol Imaging Biol 2021;23:417-426 https://doi.org/10.1007/s11307-020-01574-w
  8. Park I, Lupo JM, Nelson SJ. Correlation of tumor perfusion between carbon-13 imaging with hyperpolarized pyruvate and dynamic susceptibility contrast MRI in pre-clinical model of glioblastoma. Mol Imaging Biol 2019;21:626-632 https://doi.org/10.1007/s11307-018-1275-y
  9. Park I, Mukherjee J, Ito M, et al. Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells. Cancer Res 2014;74:7115-7124 https://doi.org/10.1158/0008-5472.CAN-14-0849
  10. Park S, Rintaro H, Kim SK, Park I. Characterization of distinctive in vivo metabolism between enhancing and non-enhancing gliomas using hyperpolarized carbon-13 MRI. Metabolites 2021;11:504 https://doi.org/10.3390/metabo11080504
  11. Crane JC, Olson MP, Nelson SJ. SIVIC: open-source, standards-based software for DICOM MR spectroscopy workflows. Int J Biomed Imaging 2013;2013:169526
  12. Chen J, Patel TR, Pinho MC, et al. Preoperative imaging of glioblastoma patients using hyperpolarized 13C pyruvate: potential role in clinical decision making. Neurooncol Adv 2021;3:vdab092
  13. Tran M, Latifoltojar A, Neves JB, et al. First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma. BJR Case Rep 2019;5: 20190003 https://doi.org/10.1259/bjrcr.20190003
  14. Duwel S, Durst M, Gringeri CV, et al. Multiparametric human hepatocellular carcinoma characterization and therapy response evaluation by hyperpolarized (13) C MRSI. NMR Biomed 2016;29:952-960 https://doi.org/10.1002/nbm.3561
  15. Rui L. Energy metabolism in the liver. Compr Physiol 2014;4:177-197 https://doi.org/10.1002/cphy.c130024
  16. Cho A, Eskandari R, Miloushev VZ, Keshari KR. A non-synthetic approach to extending the lifetime of hyperpolarized molecules using D2O solvation. J Magn Reson 2018;295:57-62 https://doi.org/10.1016/j.jmr.2018.08.001
  17. Gordon JW, Hansen RB, Shin PJ, Feng Y, Vigneron DB, Larson PEZ. 3D hyperpolarized C-13 EPI with calibrationless parallel imaging. J Magn Reson 2018;289:92-99 https://doi.org/10.1016/j.jmr.2018.02.011
  18. Ohliger MA, Larson PE, Bok RA, et al. Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance spectroscopic imaging (MRSI). J Magn Reson Imaging 2013;38:701-713 https://doi.org/10.1002/jmri.23989
  19. Pedersen H, Kozerke S, Ringgaard S, Nehrke K, Kim WY. k-t PCA: temporally constrained k-t BLAST reconstruction using principal component analysis. Magn Reson Med 2009;62:706-716 https://doi.org/10.1002/mrm.22052
  20. Wespi P, Steinhauser J, Kwiatkowski G, Kozerke S. High-resolution hyperpolarized metabolic imaging of the rat heart using k-t PCA and k-t SPARSE. NMR Biomed 2018;31
  21. Qiao K, Le Page LM, Chaumeil MM. Non-invasive differentiation of M1 and M2 activation in macrophages using hyperpolarized 13C MRS of pyruvate and DHA at 1.47 Tesla. Metabolites 2021;11:410 https://doi.org/10.3390/metabo11070410
  22. Miller JJ, Lau AZ, Nielsen PM, et al. Hyperpolarized [1,4-13C2]fumarate enables magnetic resonance-based imaging of myocardial necrosis. JACC Cardiovasc Imaging 2018;11:1594-1606 https://doi.org/10.1016/j.jcmg.2017.09.020